REQUEST A DEMO
Total
USD $0.00
Search more companies

Karyotica Biologicals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Karyotica Biologicals Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Karyotica Biologicals Private Limited is an unlisted company, incorporated on 18/07/2012. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24232TG2012PTC082062 and registration number is 082062. The company is an agriculture, forestry, fishing company, it is engaged in production of crops and animals.

Legal Address
B308, The Platina, Survey No.136, Gachibowli
Rangareddy; Andhra Pradesh; Postal Code: 500032

Contact Details: Purchase the Karyotica Biologicals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Karyotica Biologicals Private Limited report to view the information.
Outstanding Shares:
Purchase the Karyotica Biologicals Private Limited report to view the information.
Registered Capital:
Purchase the Karyotica Biologicals Private Limited report to view the information.
Incorporation Date:
July 18, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Karyotica Biologicals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
29.19%
Total operating revenue
27.91%
Operating profit (EBIT)
40.35%
EBITDA
33.05%
Net Profit (Loss) for the Period
41.37%
Total assets
201.6%
Total equity
75.31%
Operating Profit Margin (ROS)
1.29%
Net Profit Margin
1.05%
Return on Equity (ROE)
-10.31%
Debt to Equity Ratio
158.07%
Quick Ratio
-1.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?